Corrigendum to "The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases".
Shuang ChenHongmei JiangHanhui PengXiaosong WuJun FangPublished in: Oxidative medicine and cellular longevity (2018)
[This corrects the article DOI: 10.1155/2017/6504518.].